Remel, Inc

Remel, Inc: 3 recalls listed since February 2026 across FDA.

By year

GC Agar Base may have reduced or no recovery of some strains of Neisseria gonorrhoeae.

Moderate riskFDAJun 30, 2026Device defect

Yeastone Broth may report incorrect AST results during quality control, potentially causing delayed response or need to change antifungal agent.

Moderate riskFDAApr 10, 2026Device defect

Campy CVA Medium may have low recovery of Campylobacter Jejuni.

Moderate riskFDAFeb 26, 2026Device defect